scholarly journals Respiratory viral infections do not explain the winter peak in heart failure

Respirology ◽  
2021 ◽  
Author(s):  
Catherina L. Chang ◽  
Robert J. Hancox ◽  
Chris Mansell ◽  
Sarah M. Fairweather ◽  
Eskandarain Shafuddin
Keyword(s):  
Heart Failure ◽  
Viral Infections ◽  
Winter Peak ◽  
Respiratory Viral Infections

scholarly journals To the Issue of Acute Myocarditis

2019 ◽  
Vol 5 (4) ◽  
pp. 108-112
Author(s):  
E. Mokina ◽  
E. Naumenko ◽  
D. Kumanyaeva ◽  
M. Rakhmatullina ◽  
E. Surgaeva
Keyword(s):  
Heart Failure ◽  
Cardiovascular System ◽  
Viral Infections ◽  
Acute Myocarditis ◽  
Controversial Issues ◽  
Historical Aspect ◽  
Respiratory Viral Infections ◽  
Additional Therapy

According to statistics, pathology of the cardiovascular system can occur in 80% of patients who have undergone various acute viral infections, including influenza. All these manifestations are compensatory in nature and are completed independently without additional therapy. Children have respiratory viral infections, arising heart failure and various rhythm disturbances, quite often with a protracted course. Perhaps the emergence of an acute process, as well as the presence of viruses that can cause difficulties in terms of diagnosis and diagnosis, and other controversial issues. This attempt to highlight some controversial points. The detailed historical aspect of the formation of this nosological unit.

scholarly journals THE VALUE OF ACUTE RESPIRATORY VIRAL INFECTIONS IN THE DEVELOPMENT OF CHRONIC HEART FAILURE DISEASE IN CHILDREN

2012 ◽  
Vol 17 (3) ◽  
pp. 42-46 ◽  
Author(s):  
T. A. Ruzhentsova ◽  
A. V Gorelov
Keyword(s):  
Heart Failure ◽  
Chronic Heart Failure ◽  
Viral Infections ◽  
Laboratory Features ◽  
Respiratory Viral Infections ◽  
One Year

The data on clinical, ECG, ultrasound and laboratory features of myocarditides that developed in children with acute respiratory viral infections (ARVI) have been presented in this article. The dynamics of changes and the identified possibility of forming the chronic pathology in a one year after the onset of the disease has been shown.

scholarly journals Clinical efficacy of acute respiratory viral infections prevention in patients with chronic heart failure

2019 ◽  
Vol 91 (3) ◽  
pp. 36-41 ◽  
Author(s):  
A V Budnevsky ◽  
A D Shurupova ◽  
A Ya Kravchenko ◽  
R E Tokmachev
Keyword(s):  
Heart Failure ◽  
Chronic Heart Failure ◽  
Standard Therapy ◽  
Hospital Admissions ◽  
Viral Infections ◽  
Clinical Course ◽  
Functional Class ◽  
Dynamic Monitoring ◽  
Interferon Inducer ◽  
Respiratory Viral Infections

The aim of the study was to evaluate the ARVI prevention effectiveness in patients with chronic heart failure (CHF) using interferon inducer amixin. Materials and methods. Conducted a comprehensive survey, dynamic monitoring and treatment of 60 patients aged from 49 to 70 years (mean age 60.25±4.57 years, 17 men and 43 women) with CHF with preserved ejection fraction of left ventricle (LVEF) (≥50%), II-III functional class (FC) according to the classification of new York Heart Association (NYHA), which developed as a result of coronary heart disease (CHD), hypertensive disease (HD). Of these, 30 patients (group 1) on the background of standard therapy for CHF received for the prevention of ARVI tiloron (Amixin) at a dose of 125 mg once a week for 6 weeks, two courses for 1 year. Group 2 patients received only standard therapy for CHF. Results. A decrease in the frequency of ARVI in patients with CHF treated with Amixin was found, which was accompanied by a decrease in the severity of subclinical inflammation by reducing the production of proinflammatory (IL-1β) and increasing the production of anti-inflammatory (IL-10) cytokines, reducing neurohumoral activation (reducing levels of aldosterone and Nt-proBNP), increasing the level of α- and γ-interferon. The positive dynamics of biomarkers of systemic inflammation and neurohormonal activation explains the improvement of the clinical course in patients with CHF (increase of tolerance to physical loads, reducing the number of visits to General practitioner and hospital admissions in the hospital during 12 months of observation). Conclusion. A promising approach to the prevention of SARS in patients with CHF is course therapy with Amixin (2 times a year before the seasonal rising in the incidence of respiratory viral infections and influenza), which allows to achieve both decreasing in the frequency of SARS per year, and improvement the clinical course of CHF.

scholarly journals Reduction in heart failure admissions with concomitant respiratory viral infections during the novel coronavirus disease-2019 pandemic: Unintended consequence of public health measures in Singapore

2021 ◽  
Vol 27 (1) ◽  
pp. 117-119
Author(s):  
Liang EN Wee ◽  
Edwin Philip Conceicao ◽  
Jing Yuan Tan ◽  
Laura Li-Hua Chan ◽  
Poh Choo Phoon ◽  
...  
Keyword(s):  
Public Health ◽  
Heart Failure ◽  
Viral Infections ◽  
Unintended Consequence ◽  
The Novel ◽  
Health Measures ◽  
Respiratory Viral Infections ◽  
Novel Coronavirus

Homeopathic remedies to prevent and treat children acute respiratory viral infections: a comparative efficacy and safety analysis

2015 ◽  
Vol 71 (7) ◽  
pp. 71-75
Author(s):  
S.O. Mokiya-Serbina ◽  
◽  
V.V. Chechel ◽  
N.I. Zabolotnyaya ◽  
◽  
...  
Keyword(s):  
Viral Infections ◽  
Safety Analysis ◽  
Efficacy And Safety ◽  
Comparative Efficacy ◽  
Respiratory Viral Infections ◽  
Homeopathic Remedies

Chemokines in Respiratory Viral Infections: Focus on Their Diagnostic and Therapeutic Potential

2011 ◽  
Vol 31 (4) ◽  
pp. 341-356 ◽  
Author(s):  
Virginia Amanatidou ◽  
Apostolos Zaravinos ◽  
Stavros Apostolakis ◽  
Demetrios A. Spandidos
Keyword(s):  
Viral Infections ◽  
Therapeutic Potential ◽  
Respiratory Viral Infections

SYNDROME OF SYSTEMIC INFLAMMATORY RESPONSE IN PATIENTS WITH ACUTE RESPIRATORY VIRAL INFECTIONS OF CHILDREN

2017 ◽  
Vol 96 (4) ◽  
pp. 22-27 ◽  
Author(s):  
I. V. Babachenko ◽  
◽  
L. A. Alekseeva ◽  
O. M. Ibragimova ◽  
Т. V. Bessonova ◽  
...  
Keyword(s):  
Inflammatory Response ◽  
Viral Infections ◽  
Systemic Inflammatory Response ◽  
Respiratory Viral Infections

scholarly journals Corticosteroid use in respiratory viral infections - friend or foe?

2021 ◽  
Author(s):  
Zhao-Yong Lee ◽  
John Kit Chung Tam ◽  
Thai Tran
Keyword(s):  
Viral Infections ◽  
Respiratory Viral Infections
Sign in / Sign up

Export Citation Format

Share Document